Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of palbociclib with aromatase inhibitors for the treatment of advanced breast cancer in an exposure retrospective cohort study: implications for clinical practice.
Alves da Costa F, Cardoso Borges F, Ramos A, Mayer A, Brito C, Ramos C, Bernardo C, Cossito M, Furtado C, Ferreira AR, Martins-Branco D, da Costa Miranda A, Lourenço A. Alves da Costa F, et al. Breast Cancer Res. 2023 Jun 29;25(1):78. doi: 10.1186/s13058-023-01678-5. Breast Cancer Res. 2023. PMID: 37386484 Free PMC article.
Real-world effectiveness of palbociclib plus fulvestrant in advanced breast cancer: Results from a population-based cohort study.
Cardoso Borges F, Alves da Costa F, Ramos A, Ramos C, Bernardo C, Brito C, Mayer-da-Silva A, Furtado C, Ferreira AR, Martins-Branco D, Miranda A, Lourenço A. Cardoso Borges F, et al. Among authors: alves da costa f. Breast. 2022 Apr;62:135-143. doi: 10.1016/j.breast.2022.02.005. Epub 2022 Feb 8. Breast. 2022. PMID: 35182993 Free PMC article.
National trends in the use of oral chemotherapy over 13 years.
Moreira A, Bernardo C, Ramos C, Aguiar P, Alves da Costa F. Moreira A, et al. Among authors: alves da costa f. Front Pharmacol. 2022 Aug 10;13:909948. doi: 10.3389/fphar.2022.909948. eCollection 2022. Front Pharmacol. 2022. PMID: 36034797 Free PMC article.
International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
Oerlemans S, Efficace F, Kyriakou C, Freitas AC, Shamieh O, Creutzberg CL, Lehmann J, Petranovic D, Nagele E, Bredart A, Dong D, Scholz CW, Caocci G, Molica S, Griskevicius L, Xochelli A, Kieffer JM, Agelink van Rentergem JA, Alrjoub W, Mueller A, Gomes Da Silva M, Alves da Costa F, Malak S, Cocks K, van de Poll-Franse LV; EORTC Quality of Life Group. Oerlemans S, et al. Among authors: alves da costa f. Cancer. 2023 Sep 1;129(17):2727-2740. doi: 10.1002/cncr.34822. Epub 2023 May 19. Cancer. 2023. PMID: 37204189
A cross-sectional survey to map Clinical Pharmacy Education and Practice in Europe.
Moura L, Steurbaut S, Salvesen Blix H, Addison B, Rabus S, Mota-Filipe H, Alves da Costa F; ESCP Education Committee. Moura L, et al. Among authors: alves da costa f. Int J Clin Pharm. 2022 Feb;44(1):118-126. doi: 10.1007/s11096-021-01321-3. Epub 2021 Sep 9. Int J Clin Pharm. 2022. PMID: 34498216
Identification of potentially inappropriate medications with risk of major adverse cardiac and cerebrovascular events among elderly patients in ambulatory setting and long-term care facilities.
Aguiar JP, Heitor Costa L, Alves da Costa F, Leufkens HG, Martins AP. Aguiar JP, et al. Among authors: alves da costa f. Clin Interv Aging. 2019 Mar 4;14:535-547. doi: 10.2147/CIA.S192252. eCollection 2019. Clin Interv Aging. 2019. PMID: 30880934 Free PMC article.
55 results